In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Albemarle trades 49% above a PERT-weighted fair value of $85.63 despite high confidence in valuation models. DCF analysis shows significant negative value, while analyst targets and price/sales suggest higher valuations, indicating model divergence. Financial health reveals strong liquidity and leverage but zero profitability and efficiency, increasing investment risk.